More articles from ENDOCRINE AND DIABETES

You have access
Preventive and Therapeutic Potential of p38α-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 Diabetes
Satyanarayana Medicherla, Andrew A. Protter, Jing Ying Ma, Ruban Mangadu, Ramona Almirez, Bruce Koppelman, Irene Kerr, Tony A. Navas, Fabiola Movius, Mamatha Reddy, Yu-Wang Liu, Gregory Luedtke, John Perumattam, Babu Mavunkel, Sundeep Dugar and George F. Schreiner

Journal of Pharmacology and Experimental Therapeutics July 2006, 318 (1) 99-107; DOI: https://doi.org/10.1124/jpet.105.097857
You have access
A Novel Partial Agonist of the A₁ -Adenosine Receptor and Evidence of Receptor Homogeneity in Adipocytes
Marjan Fatholahi, Yiwen Xiang, Yuzhi Wu, Yuan Li, Lin Wu, Arvinder K. Dhalla, Luiz Belardinelli and John C. Shryock

Journal of Pharmacology and Experimental Therapeutics May 2006, 317 (2) 676-684; DOI: https://doi.org/10.1124/jpet.105.099119
You have access
Preclinical Pharmacology of a Nonsteroidal Ligand for Androgen Receptor-Mediated Imaging of Prostate Cancer
Jun Yang, Casey E. Bohl, Vipin A. Nair, Suni M. Mustafa, Seoung Soo Hong, Duane D. Miller and James T. Dalton

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 402-408; DOI: https://doi.org/10.1124/jpet.105.094334
You have access
A Model of Controlled Acute Hyperglycemia in Rats: Effects of Insulin and Glucagon-Like Peptide-1 Analog
Joy K. Saha, Jinqi Xia, Steven K. Engle, Yun-Fei Chen, Wolfgang Glaesner and Joseph A. Jakubowski

Journal of Pharmacology and Experimental Therapeutics March 2006, 316 (3) 1159-1164; DOI: https://doi.org/10.1124/jpet.105.093534
You have access
Blood Glucose-Lowering Nuclear Receptor Agonists Only Partially Normalize Hepatic Gene Expression in db/db Mice
Michael Loffler, Martin Bilban, Mark Reimers, Werner Waldhäusl and Thomas M. Stulnig

Journal of Pharmacology and Experimental Therapeutics February 2006, 316 (2) 797-804; DOI: https://doi.org/10.1124/jpet.105.093831
You have access
Long-Term Treatment with Novel Glycogen Synthase Kinase-3 Inhibitor Improves Glucose Homeostasis in ob/ob Mice: Molecular Characterization in Liver and Muscle
Oksana Kaidanovich-Beilin and Hagit Eldar-Finkelman

Journal of Pharmacology and Experimental Therapeutics January 2006, 316 (1) 17-24; DOI: https://doi.org/10.1124/jpet.105.090266
You have access
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
Thomas H. Claus, Derek B. Lowe, Yin Liang, Arthur I. Salhanick, Christine Keiper Lubeski, Ling Yang, Lynn Lemoine, Jian Zhu and Kevin B. Clairmont

Journal of Pharmacology and Experimental Therapeutics December 2005, 315 (3) 1396-1402; DOI: https://doi.org/10.1124/jpet.105.086926
You have access
Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats
B. F. Burkey, X. Li, L. Bolognese, B. Balkan, M. Mone, M. Russell, T. E. Hughes and P. R. Wang

Journal of Pharmacology and Experimental Therapeutics November 2005, 315 (2) 688-695; DOI: https://doi.org/10.1124/jpet.105.087064
You have access
The Para Substituent of S-3-(Phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides Is a Major Structural Determinant of in Vivo Disposition and Activity of Selective Androgen Receptor Modulators
Juhyun Kim, Di Wu, Dong Jin Hwang, Duane D. Miller and James T. Dalton

Journal of Pharmacology and Experimental Therapeutics October 2005, 315 (1) 230-239; DOI: https://doi.org/10.1124/jpet.105.088344

Main menu

User menu

Search

More articles from ENDOCRINE AND DIABETES

Pages

Navigate

More Information

ASPET's Other Journals